Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ±...

  • Main
  • 2017 / 11
  • Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ±...

Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with HCV genotype 2, 4, 5, or 6 infection: the C-SCAPE study

Brown, A., Hézode, C., Zuckerman, E., Foster, G. R., Zekry, A., Roberts, S. K., Lahser, F., Durkan, C., Badshah, C., Zhang, B., Robertson, M., Wahl, J., Barr, E., Haber, B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Viral Hepatitis
DOI:
10.1111/jvh.12801
Date:
November, 2017
File:
PDF, 733 KB
english, 2017
Conversion to is in progress
Conversion to is failed